Cognitive behavioral therapy for insomnia is the gold standard treatment recommended by every major sleep medicine organization. The problem is that most people who need it cannot get it. There are not enough trained therapists, and for older adults who may face mobility limitations, transportation barriers, or live in rural areas, the gap between recommendation and reality is even wider.
A clinical trial from the University of Virginia School of Medicine suggests that a digital program called SHUTi OASIS could help bridge that gap. The study found that the online intervention produced meaningful sleep improvements that persisted for at least a year in adults aged 55 to 95.
What Is SHUTi OASIS?
SHUTi OASIS—which stands for Sleep Healthy Using the Internet for Older Adults Suffering with Insomnia and Sleeplessness—is the first digital health program for insomnia designed specifically for older adults. It delivers the core principles of cognitive behavioral therapy for insomnia through an interactive online platform that patients work through at their own pace.
The program is built on SHUTi, an earlier version designed for the general adult population that proved successful in multiple large trials. SHUTi OASIS was adapted to address the specific needs of older adults, including age-related changes in sleep architecture, higher rates of medical comorbidities, and different technology comfort levels.
The Clinical Trial
The randomized controlled trial enrolled 311 participants aged 55 to 95. They were divided into three groups:
- SHUTi OASIS alone (105 participants)
- SHUTi OASIS with stepped support from a health coach (102 participants)
- Standard online patient education as a control group (104 participants)
Researchers measured outcomes at post-treatment, six months, and twelve months. Both SHUTi OASIS groups significantly outperformed the patient education group across nearly every measure.
A year after using the program, two to three times more participants in the SHUTi OASIS groups showed meaningful sleep improvements compared to the control group.
Improvements Across the Board
The benefits were not limited to a single sleep metric. Participants who received SHUTi OASIS showed significant improvements in:
- Insomnia severity as measured by standardized clinical scales
- Sleep onset latency—the time it takes to fall asleep
- Wake after sleep onset—time spent awake in the middle of the night
- Sleep efficiency—the percentage of time in bed actually spent sleeping
- Number of nighttime awakenings
- Subjective sleep quality
- Daytime fatigue
These improvements held up at the six-month and twelve-month follow-up assessments, suggesting that the skills patients learned through the program created lasting changes in their sleep habits.
Why Older Adults Need Different Approaches
Insomnia is particularly common among older adults, affecting an estimated 30 to 48% of people over 60. Yet this population faces unique barriers to treatment.
Many older adults are prescribed sleep medications as a first-line approach, despite growing evidence that drugs like benzodiazepines and Z-drugs carry serious risks for older people, including falls, cognitive impairment, and dependency. The American Geriatrics Society's Beers Criteria specifically recommends against these medications in older adults.
Cognitive behavioral therapy for insomnia avoids these risks by teaching patients to change the thoughts and behaviors that perpetuate poor sleep. But with a severe shortage of trained CBT-I providers—estimated at fewer than a few thousand nationally—most older adults never receive the recommended treatment.
The findings suggest the online program could help many older people who do not have access to in-person treatment because of location or cost.
A Comparative Medication Trial Is Coming
The need for better insomnia treatment options extends beyond digital therapy. Penn Medicine is conducting a large-scale trial comparing five commonly prescribed insomnia medications—trazodone, zolpidem, doxepin, melatonin, and diphenhydramine—against a placebo in more than 1,000 primary care patients.
The trial aims to determine how these medications perform under real-world conditions, which is important because insomnia is most often treated in primary care settings rather than specialized sleep clinics.
What Patients Can Do Now
For older adults struggling with insomnia, several evidence-based strategies can help while digital programs like SHUTi OASIS become more widely available:
- Maintain a consistent sleep schedule even on weekends
- Limit time in bed to the hours you are actually sleeping to build stronger sleep drive
- Get out of bed if you cannot sleep after 15 to 20 minutes, and return only when sleepy
- Avoid napping late in the day as it can reduce nighttime sleep pressure
- Talk to your doctor about non-medication options before starting or continuing sleep drugs
The SHUTi OASIS results offer encouraging evidence that effective insomnia treatment can be delivered digitally, at scale, and to the population that may need it most.
